Researchers describe the underlying signaling pathway that results in pulmonary arterial hypertension and a novel monoclonal antibody therapy that blocks the abnormal blood vessel formation characterizing the disease.
Click here for original story, Targeting molecular pathway that causes pulmonary arterial hypertension
Source: ScienceDaily